Nitrosamine Impurities Application Guide - Confidently Detect and Quantify Mutagenic Impurities in APIs and Drug Products
Guides, Presentations | 2020 | Agilent TechnologiesInstrumentation
GC/MSD, GC/MS/MS, HeadSpace, GC/SQ, GC/QQQ, LC/TOF, LC/HRMS, LC/MS, LC/MS/MS, LC/QQQ
IndustriesPharma & Biopharma
ManufacturerAgilent Technologies
Key wordsback, ndma, neipa, fda, ndipa, ndea, ndba, metformin, nitrosamine, introduction, api, valsartan, best, quant, dichloromethan, candesartan, telmisartan, ranitidine, sartan, substance, sample, losartan, filter, curves, drug, preparation, sonicate, optimized, supernatant, method, time, vial, counts, calibrations, impurities, temperature, scalable, per, labs, name, centrifugation, recovery, masshunter, paper, irbesartan, olmesartan, drugs, rugged, calibration, easy
Similar PDF
Nitrosamines Analysis in Pharmaceuticals - Consumables workflow ordering guide
2021|Agilent Technologies|Guides
Nitrosamines Analysis in Pharmaceuticals Using Single Quadrupole GC/MS or Triple Quadrupole GC/MS Consumables workflow ordering guide R1 N N R2 R O 2 R 1 R N N 2 R 1 R O R 2 1 N N N N…
Key words
nitrosamine, nitrosaminenitrosamines, nitrosaminesndma, ndmandea, ndeamylist, mylistfavorite, favoriteneipa, neipandipa, ndipadrug, drugppm, ppmitems, itemsinlet, inletclick, clickreplacement, replacementsupplies
Quantification of Nitrosamine Impurities in Metformin Using Agilent GC/MS/MS Instrumentation
2020|Agilent Technologies|Applications
Application Note Pharma and Biopharma Quantification of Nitrosamine Impurities in Metformin Using Agilent GC/MS/MS Instrumentation Authors Soma Dasgupta, Vivek Dhyani, Samir Vyas, and Melissa Churley, Agilent Technologies, Inc. Abstract Since June 2018, several drugs were recalled due to the presence…
Key words
ndma, ndmandea, ndeacounts, countsacquisition, acquisitiondrug, drugname, namendba, ndbanitrosamine, nitrosaminemin, minneipa, neipandipa, ndipaweighed, weighedϭϭϯ, ϭϭϯїϱϲ͘ϭ͕, їϱϲ͘ϭ͕time
Analysis of Five Nitrosamine Impurities in Drug Products and Drug Substances Using Agilent GC/MS/MS Instrumentation
2020|Agilent Technologies|Applications
Application Note Pharma & Biopharma Analysis of Five Nitrosamine Impurities in Drug Products and Drug Substances Using Agilent GC/MS/MS Instrumentation Authors Soma Dasgupta, Lalith Hansoge, Vivek Dhyani, Samir Vyas, and Melissa Churley Agilent Technologies, Inc. Abstract This application note highlights…
Key words
relative, relativeresponses, responsesndba, ndbaneipa, neipandipa, ndipandma, ndmaotr, otrndea, ndeastd, stdfda, fdacounts, countsconcentration, concentrationacquisition, acquisitiondrug, drugimpurities
Analysis of Pharmaceuticals’ Impurity - Regulations and Analysis for Carcinogenic Substances -
2020|Shimadzu|Guides
Application Note No. 62 Analysis of Pharmaceuticals’ Impurity - Regulations and Analysis for Carcinogenic Substances Dheeraj Handique *a), Nitish Suryawanshi *a), Crystal Yeong *b), Cynthia Lahey *b), Shailendra Rane *a), Deepti Bhandarkar *a), Anant Lohar *a), Gao Jie san *c),…
Key words
ndma, ndmandea, ndeacarcinogenic, carcinogenicsubstances, substancesmutagenic, mutagenicmms, mmsems, emsimpurity, impuritymode, modeims, imsmutagenicity, mutagenicitydrug, drugolmesartan, olmesartanndba, ndbandipa